HAEMOCTIN SDH 1000 IU İsrail - İngilizce - Ministry of Health

haemoctin sdh 1000 iu

kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

FANHDI 25 IUML (FACTOR VIII) İsrail - İngilizce - Ministry of Health

fanhdi 25 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 50 IUML (FACTOR VIII) İsrail - İngilizce - Ministry of Health

fanhdi 50 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 100 IUML (FACTOR VIII) İsrail - İngilizce - Ministry of Health

fanhdi 100 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

Recombinate 1000 IU, powder and solvent for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

recombinate 1000 iu, powder and solvent for solution for injection

baxalta innovations gmbh - factor viii, human recombinant - powder and solvent for solution for injection - 1000 iu international unit(s) - blood coagulation factors; coagulation factor viii - antihaemorrhagics: blood coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). this product does not contain von willebrand factor and is therefore not indicated in von willebrand’s disease

BIOSTATE human coagulation factor VIII 500IU / von Willebrand Factor 1200IU powder for injection vial with diluent vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

biostate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.

BIOSTATE human coagulation factor VIII 250IU / von Willebrand Factor 600IU powder for injection vial with diluent vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

biostate human coagulation factor viii 250iu / von willebrand factor 600iu powder for injection vial with diluent vial

csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.

HAEMOCTIN PS.INJ.SOL 250 IU/VIAL Yunanistan - Yunanca - Εθνικός Οργανισμός Φαρμάκων

haemoctin ps.inj.sol 250 iu/vial

biotest pharma gmbh, germany landsteinerstraße 5, 63303 dreieich +49(0) 6103 801-0 - factor viii:c (human coagulation factor) - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 250 iu/vial - factor viii:c (human coagulation factor) 50iu - coagulation factor viii

HAEMOCTIN PS.INJ.SOL 500 IU/VIAL Yunanistan - Yunanca - Εθνικός Οργανισμός Φαρμάκων

haemoctin ps.inj.sol 500 iu/vial

biotest pharma gmbh, germany landsteinerstraße 5, 63303 dreieich +49(0) 6103 801-0 - factor viii:c (human coagulation factor) - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 500 iu/vial - factor viii:c (human coagulation factor) 50iu - coagulation factor viii

HAEMOCTIN PS.INJ.SOL 1000 IU/VIAL Yunanistan - Yunanca - Εθνικός Οργανισμός Φαρμάκων

haemoctin ps.inj.sol 1000 iu/vial

biotest pharma gmbh, germany landsteinerstraße 5, 63303 dreieich +49(0) 6103 801-0 - factor viii:c (human coagulation factor) - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 1000 iu/vial - factor viii:c (human coagulation factor) 200iu - coagulation factor viii